Wren Laboratories Limited is a privately held limited company established in 2004, operating from its headquarters at 21 & 22 Mayfield Avenue Industrial Estate, Fyfield Road, Andover, SP11 8HU. Currently, the company is registered under Reg: 05094520 and maintains a status of active. Wren specializes in the research, development, and manufacturing of advanced mRNA diagnostic solutions. The company’s core focus is dedicated to improving cancer care through the creation of innovative diagnostic tools. This includes developing and producing highly sensitive and specific mRNA-based tests for early cancer detection and monitoring. Beyond diagnostics, Wren Laboratories is actively engaged in accelerating drug development processes utilizing mRNA technology. The company’s strategic approach prioritizes precision medicine, aiming to provide clinicians with enhanced diagnostic capabilities and personalized treatment options. Wren Laboratories operates internationally, demonstrating a commitment to global collaboration and market expansion. The company employs a skilled workforce and actively seeks to recruit talented individuals. The company’s SIC codes encompass various manufacturing and related industries, including but not limited to: Medical Devices, Pharmaceuticals, Biotechnology, and Diagnostic Equipment.

Wren Laboratories Limited is a privately held limited company established in 2004, operating from its headquarters at 21 & 22 Mayfield Avenue Industrial Estate, Fyfield Road, Andover, SP11 8HU. Currently, the company is registered under Reg: 05094520 and maintains a status of active. Wren specializes in the research, development, and manufacturing of advanced mRNA diagnostic solutions. The company’s core focus is dedicated to improving cancer care through the creation of innovative diagnostic tools. This includes developing and producing highly sensitive and specific mRNA-based tests for early cancer detection and monitoring. Beyond diagnostics, Wren Laboratories is actively engaged in accelerating drug development processes utilizing mRNA technology. The company’s strategic approach prioritizes precision medicine, aiming to provide clinicians with enhanced diagnostic capabilities and personalized treatment options. Wren Laboratories operates internationally, demonstrating a commitment to global collaboration and market expansion. The company employs a skilled workforce and actively seeks to recruit talented individuals. The company’s SIC codes encompass various manufacturing and related industries, including but not limited to: Medical Devices, Pharmaceuticals, Biotechnology, and Diagnostic Equipment.